NCT01650675

Brief Summary

The purpose of this study is to assess the validity of an indirect computer-delivered screener for drug use and assess the efficacy of a computer-delivered brief intervention with urban post-partum women at-risk for substance abuse and HIV during the post-partum period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jun 2012

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 13, 2012

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 26, 2012

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
Last Updated

December 8, 2015

Status Verified

December 1, 2015

Enrollment Period

2.4 years

First QC Date

July 13, 2012

Last Update Submit

December 7, 2015

Conditions

Keywords

pregnancyscreeningmotivation

Outcome Measures

Primary Outcomes (3)

  • Number of drug using days

    Drug use over past 90 days will be measured at a 3 and 6-month follow-up by self-report, hair, and urine analysis.

    since last research visit; up to 90 days prior to current evaluation

  • Change from Baseline HIV and other STI risk at 3 months

    Self-report of risky sexual and/or injection drug use that could place participants at risk of HIV and other STIs

    since last research visit; up to 90 days from baseline visit

  • Change from Baseline in HIV and Other STI Risk at 6 months

    Self-report of risky sexual and/or injection drug use that could place participants at risk of HIV and other STIs

    since last research visit; up to 180 days since baseline visit

Study Arms (2)

Control

PLACEBO COMPARATOR

Participants randomized into the control condition complete assessment and a time-matched interactive session on infant nutrition.

Behavioral: Nutrition time control/placebo intervention

Indirect intervention

EXPERIMENTAL

Participants in this condition review a short series of parenting strengths that benefit infants, and are invited to consider their current status in each area. This list includes factors associated with drug use (e.g., safety, emotional health) as well as substance use itself.

Behavioral: WIDUS computer-delivered, indirect brief intervention

Interventions

A single 20-minute interactive computer-delivered intervention designed to promote motivation to change drug use and risky sexual behavior, if any, without presuming those risks to be specifically present.

Indirect intervention

This time-control intervention, designed in part to help promote RA blinding as to participant condition, focuses on proper infant nutrition using a computer-delivered, interactive format and videos.

Control

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years of age or older
  • able to communicate in English
  • recently gave birth to healthy infant

You may not qualify if:

  • received narcotic pain medication in past 3 hours
  • no sleep since giving birth
  • infant deceased or in intensive care
  • psychosis or other clear cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wayne State University

Detroit, Michigan, 48202, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Steven J Ondersma, Ph.D.

    Wayne State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 13, 2012

First Posted

July 26, 2012

Study Start

June 1, 2012

Primary Completion

November 1, 2014

Study Completion

May 1, 2015

Last Updated

December 8, 2015

Record last verified: 2015-12

Locations